Enveric Biosciences, a notable player in biotechnological innovations, has recently announced a significant licensing agreement that might change the landscape of cancer treatment. According to a recent press release from the company, a non-binding term sheet has been signed with an undisclosed licensee, aiming to use patented methods that incorporate cannabinoids with chemotherapeutic drugs to treat breast and other types of cancer.
